Cyclin G2: A novel independent prognostic marker in pancreatic cancer.
about
Comprehensive phenotypic analysis of knockout mice deficient in cyclin G1 and cyclin G2.Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells.CCNG2 Overexpression Mediated by AKT Inhibits Tumor Cell Proliferation in Human Astrocytoma Cells.miR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas
P2860
Cyclin G2: A novel independent prognostic marker in pancreatic cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Cyclin G2: A novel independent prognostic marker in pancreatic cancer.
@ast
Cyclin G2: A novel independent prognostic marker in pancreatic cancer.
@en
type
label
Cyclin G2: A novel independent prognostic marker in pancreatic cancer.
@ast
Cyclin G2: A novel independent prognostic marker in pancreatic cancer.
@en
prefLabel
Cyclin G2: A novel independent prognostic marker in pancreatic cancer.
@ast
Cyclin G2: A novel independent prognostic marker in pancreatic cancer.
@en
P2093
P2860
P356
P1433
P1476
Cyclin G2: A novel independent prognostic marker in pancreatic cancer.
@en
P2093
Akira Tomokuni
Hideshi Ishii
Hidetoshi Eguchi
Hiroaki Nagano
Hiroshi Nojima
Hiroshi Wada
Jun Koseki
Koichi Kawamoto
Masamitsu Konno
Naohiro Nishida
P2860
P304
P356
10.3892/OL.2015.3667
P577
2015-09-02T00:00:00Z